What CITY THERAPEUTICS, INC.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 2 | 2 |
| Sells | 0 | 0 |
| Total trades | 9 | 9 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 22,559,189 | 22,559,189 |
| Disposed | 0 | 0 |
| Net activity | +22,559,189 | +22,559,189 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Arch Venture Partners XII, Llc | 10% owner | Oct 19 | Open-market buy · P | +170,000 | $18.00 | +$3.06M | 13,692,507 |
| Arch Venture Partners XII, Llc | 10% owner | Oct 19 | Derivative Conversion · C | +2,027,006 | — | — | 13,522,507 |
| Arch Venture Partners XII, Llc | 10% owner | Oct 19 | Derivative Conversion · C | +5,482,309 | — | — | 11,495,501 |
| Arch Venture Partners XII, Llc | 10% owner | Oct 19 | Derivative Conversion · C | +3,294,900 | — | — | 6,013,192 |
| Maraganore John | Director | Oct 19 | Derivative Conversion · C | +610,759 | — | — | 1,470,692 |
| Nelsen Robert | Director | Oct 19 | Open-market buy · P | +170,000 | $18.00 | +$3.06M | 13,692,507 |
| Nelsen Robert | Director | Oct 19 | Derivative Conversion · C | +2,027,006 | — | — | 13,522,507 |
| Nelsen Robert | Director | Oct 19 | Derivative Conversion · C | +5,482,309 | — | — | 11,495,501 |
| Nelsen Robert | Director | Oct 19 | Derivative Conversion · C | +3,294,900 | — | — | 6,013,192 |
Loading...
